Provided by Tiger Fintech (Singapore) Pte. Ltd.

Solid Biosciences

3.12
-0.2900-8.52%
Post-market: 3.07-0.0490-1.57%19:36 EDT
Volume:1.61M
Turnover:5.11M
Market Cap:241.39M
PE:-1.02
High:3.40
Open:3.34
Low:3.06
Close:3.41
Loading ...

Wedbush starts Solid Biosciences at Outperform on ‘potentially better’ DMD tool

TIPRANKS
·
13 Dec 2024

Solid Biosciences Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Dec 2024

JMP Securities Initiates Solid Biosciences at Market Outperform With $15 Price Target

MT Newswires Live
·
10 Dec 2024

Solid Biosciences initiated with an Outperform at JMP Securities

TIPRANKS
·
10 Dec 2024

Solid Biosciences management to meet with Piper Sandler

TIPRANKS
·
07 Dec 2024

Strategic Collaboration with Mayo Clinic Boosts Solid Biosciences’ Buy Rating for Cardiac Gene Therapy Advancements

TIPRANKS
·
06 Dec 2024

Analysts Conflicted on These Healthcare Names: Solid Biosciences (SLDB), Foghorn Therapeutics (FHTX) and KalVista Pharmaceuticals (KALV)

TIPRANKS
·
06 Dec 2024

Solid Biosciences Collaborating With Mayo Clinic to Develop Cardiac Gene Therapies

MT Newswires Live
·
04 Dec 2024

BRIEF-Solid Biosciences Announces Collaboration With Mayo Clinic To Accelerate Gene Therapy Innovation And Advance Development Of Cardiac Gene Therapies

Reuters
·
04 Dec 2024

Solid Biosciences announces collaboration with Mayo Clinic

TIPRANKS
·
04 Dec 2024

Solid Biosciences reports inducement grant under Nasdaq listing rule

TipRanks
·
04 Dec 2024

Solid Biosciences Announces Collaboration With Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies

THOMSON REUTERS
·
04 Dec 2024

Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies

GlobeNewswire
·
04 Dec 2024

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Dec 2024

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
03 Dec 2024

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire
·
26 Nov 2024

Solid Biosciences price target lowered to $12 from $15 at JPMorgan

TIPRANKS
·
12 Nov 2024

Solid Biosciences Is Maintained at Buy by Chardan Capital

Dow Jones
·
12 Nov 2024

Analysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB), Privia Health Group (PRVA) and Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
08 Nov 2024

Solid Biosciences Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Nov 2024